XBI etf prediction: up to 88.86 USD SPDR Series Trust S&P Biotech fund price price prognosis


Forecast for Fri 28 Jul 2023 price 96.72

SPDR Series Trust S&P Biotech etf price forecast for further price development up to 2.81% (time horizon: 1 day) and price target of 88.86 USD. Short-term (time horizon: 2 weeks) SPDR Series Trust S&P Biotech fund price prediction for 2023-07-28 with daily closed price projections

Key Facts

Symbol XBI 

ISIN US78464A8707 

CUSIP 78464A870

Currency USD

Forecast price change %

Finance numbers

Total Assets 7,003,734,909.89

Total Liabilities 527,832,847.55

Net Assets 6,475,902,062.34

On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

Institutional ownership list is based on filling form information

Fund ownership list is based on filling form information

Fund name Date Amount Profile
BlackRock Funds V 2022-12-31 88000 Long
BlackRock Variable Series Funds, Inc. 2022-12-31 43080 Long
LoCorr Investment Trust 2022-12-31 -3912 Short
BlackRock Large Cap Focus Value Fund, Inc. 2022-12-30 267550 Long
Voya Variable Products Trust 2022-12-30 41093 Long

Portfolio Investments Report associated with Fund SPDR SERIES TRUST

Symbol Cusip Name Amount Value Title Of Class Pay of profile
0 462222100 Ionis Pharmaceuticals Inc 1857401.0 66383511.74 CORP Long
0 602496101 MiMedx Group Inc 1590909.0 5424999.69 CORP Long
0 901384107 2seventy bio Inc 2058063.0 20992242.6 CORP Long
0 04280A100 Arrowhead Pharmaceuticals Inc 2397414.0 60894315.6 CORP Long
0 74366E102 Protagonist Therapeutics Inc 1423063.0 32730449.0 CORP Long

Bollinger Bollinger Bands for SPDR Series Trust S&P Biotech can provide the information where the market is moving based on price information.

SPDR Series Trust S&P Biotech Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.

Converting prices to returns SPDR Series Trust S&P Biotech.

On-Balance Volume information for SPDR Series Trust S&P Biotech. On-Balance Volume information can be an indicator for bullish or bearish outcome.

Accumulation / Distribution (A/D) indicator information for SPDR Series Trust S&P Biotech. The indicator identify divergences between price and volume flow.

Aroon Oscillator information for SPDR Series Trust S&P Biotech. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.

Average Directional Index (ADX) information for SPDR Series Trust S&P Biotech. The index can be used to identify the strengh of a trend.

Moving Average Convergence Divergence (MACD) for SPDR Series Trust S&P Biotech. The indicator helps to predict trend direction and the momentum of the trend.

Stochastic Oscillator as momentum indicator for SPDR Series Trust S&P Biotech. The indicator is useful for identifying overbought and oversold levels.

Relative Strength Index (RSI) for SPDR Series Trust S&P Biotech. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].

52W High 52W Low Market Cap

Similar shares

SPDR Series Trust S&P Biotech on Nasdaq

SPDR Series Trust S&P Biotech on finviz

Figure below show the etf predictions.
Date Closing price Prediction was updated
2023-06-09 88.86 2023-06-03 11:36
2023-06-12 91.33 2023-06-03 11:36
2023-06-13 89.86 2023-06-03 11:36
2023-06-14 89.89 2023-06-03 11:36
2023-06-15 87.13 2023-06-03 11:36
2023-06-06 85.05 2023-06-03 11:36
2023-06-07 86.10 2023-06-03 11:36
2023-06-08 87.34 2023-06-03 11:36
2023-06-16 86.62 2023-06-03 11:36
2023-06-19 87.50 2023-06-03 11:36
2023-06-20 90.08 2023-06-03 11:36
2023-06-21 90.38 2023-06-03 11:36
2023-06-26 87.11 2023-06-03 11:36
2023-06-27 86.40 2023-06-03 11:36
2023-06-22 89.18 2023-06-03 11:36
2023-06-23 87.84 2023-06-03 11:36
2023-06-28 89.10 2023-06-03 11:36
2023-06-29 91.27 2023-06-03 11:36
2023-06-30 92.14 2023-06-03 11:36
2023-07-03 89.88 2023-06-03 11:36
2023-07-05 85.79 2023-06-03 11:36
2023-07-04 87.77 2023-06-03 11:36
2023-07-06 87.24 2023-06-03 11:36
2023-07-07 90.21 2023-06-03 11:36
2023-07-10 92.54 2023-06-03 11:36
2023-07-11 93.17 2023-06-03 11:36
2023-07-12 91.17 2023-06-03 11:36
2023-07-13 87.82 2023-06-03 11:36
2023-07-14 86.84 2023-06-03 11:36
2023-07-17 89.34 2023-06-03 11:36
2023-07-18 93.53 2023-06-03 11:36
2023-07-19 95.08 2023-06-03 11:36
2023-07-20 94.27 2023-06-03 11:36
2023-07-21 90.53 2023-06-03 11:36
2023-07-24 86.46 2023-06-03 11:36
2023-07-25 86.10 2023-06-03 11:36
2023-07-26 89.65 2023-06-03 11:36
2023-07-27 94.59 2023-06-03 11:36
2023-07-28 96.72 2023-06-03 11:36

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.